First Half
The Exor Board of Directors’ meeting approved today the 2022 First Half-year Report.
At 30 June 2022 Exor’s NAV is €25,505 million compared to €31,069 million at 31 December 2021. At 30 June 2022 Exor’s NAV per share amounts to €109.41 compared to €132.41 at 31 December 2021, a decrease of €23.00/share or 17.4%. This compares to a decrease of 14.3% for the MSCI World Index in Euro.
The Exor Board of Directors’ meeting, chaired by John Elkann, approved today the 2021 Half-year Financial Report.
At 30 June 2021 Exor’s NAV was $32,158 million, an increase of $2,657 million (+9%) compared to $29,501 million at 31 December 2020. At 30 June 2021 the NAV per share was $136.54, an increase of $11.28 per share (+9%) compared to $125.26 at 31 December 2020.
The EXOR Board of Directors’ meeting, chaired by John Elkann, approved today the 2020 Half-year Financial Report.
At 30 June 2020 EXOR’s NAV amounted to $20,955 million, a decrease of -$5,200 million (-19.9%) compared to $26,155 million at 31 December 2019. At 30 June 2020 the NAV per share amounted to $88.75, a decrease of $22.02 per share (-19.9%) compared to $110.77 at 31 December 2019. This compares to a decrease of -6.6% for the MSCI World Index.
The Exor Board of Directors’ meeting, chaired today by John Elkann, approved the consolidated results for the first half of 2019.
At 30 June 2019 Exor’s NAV (Net Asset Value) was $23,882 million, compared to $19,740 million at 31 December 2018. NAV per share was $101.06 at 30 June 2019, compared to $82.33 at 31 December 2018, an increase of $18.73/share (+22.8%). The change in NAV per share compared to the MSCI World Index in US$ is presented below: